Research discoveries drive progress against prostate cancer, and the good news is that between 1994 and 2019, the death rate from prostate cancer has dropped by half.
Our first research grant in 1996 was essential for the development of active surveillance, an approach that monitors low risk prostate cancer and only offers treatment to patients when their disease progresses. This approach is now the international standard for early stage cancer – saving millions of men from unnecessary treatment.
The research we fund looks into prevention, early and better diagnosis, improved treatments and better quality of life for survivors.
Since 1994, in partnership with Movember Foundation, we have invested $120 million in leading Canadian research that gives hope to those affected. Annually, we invest an average of $50 million into 60+ new and ongoing projects. We support the work of more than 200 researchers at 50 universities and hospitals in nine provinces.
The new knowledge we help generate in Canada is making a difference in the lives of those affected by prostate cancer.


Donate Now!

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
$2 million invested in new prostate cancer research

Prostate Cancer Canada and Movember partner to fund ten research projects breaking new ground

Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.

Researchers discover common markers of tumour hypoxia across 19 cancer types

Landmark pan-cancer study analyzes mutation signatures of low oxygen in more than 8,000 tumours

Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  

Click here for news archive